21 C.F.R. § 522.1086

Guaifenesin solution.

Last amended: 2021Year: 2026Length: 103 wordsSubsections: 3Official source

Cite as 21 C.F.R. § 522.1086 (2026)

(a) Specifications. Each milliliter of solution contains 50 milligrams (mg) of guaifenesin and 50 mg of dextrose. (b) Sponsors. See Nos. 037990 and 058198 in § 510.600(c) of this chapter. (c) Conditions of use in horses —(1) Amount. Administer 1 milliliter per pound of body weight by rapid intravenous infusion. (2) Indications for use. For use as a skeletal muscle relaxant. (3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian. [79 FR 16189, Mar. 25, 2014, as amended at 86 FR 14820, Mar. 19, 2021]
Cross-references to the CFR
510.600
21 C.F.R. § 522.1086: Guaifenesin solution. | Justis AI